Results 111 to 120 of about 28,983 (181)

Novel regulatory mechanism of choline-O-sulfate and choline catabolism by two BetIs in Alphaproteobacteria. [PDF]

Appl Environ Microbiol
Liu J-R, Li Z-K, Wang M-C, Wang N, Wang Z-Q, Li F-F, Chen Y, Zhang Y-Z, Fu H-H.   +8 more
europepmc   +1 more source

Delito: Frontón Beti Jai

, 2018
Delito: Frontón Beti ...
openaire   +1 more source

Dataset of GenAI preferences and digital citizenship multidimensional among Indonesian students. [PDF]

Data Brief
Prasetiyo WH, Sari BI, Arif DB, Hidayat ML, Nugroho YS, Sukirman, Naidu NBM.   +6 more
europepmc   +1 more source

BET bromodomain inhibitors attenuate transcription of a subset of IL-1-induced NF-κB targets that promote inflammation in β-cells. [PDF]

J Biol Chem
Nord JA, Makowski SJ, Sidlowski PFW, Bursch KL, Corbett JA, Smith BC.   +5 more
europepmc   +1 more source

The Role of Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in the Tumor Microenvironment and Their Impact on Ovarian Cancer Survival and Therapy. [PDF]

Curr Oncol
McQuarter AA, Cruz J, Yamauchi CR, Chouchen M, Carter CS, Webb TJ, Khan S.   +6 more
europepmc   +1 more source

Mapping the Crystallographic Landscape of Antivitamin Ionic Liquids: Structural Blueprints for Novel Architectures. [PDF]

Cryst Growth Des
McNeill C, Scheuren M, Cooper J, Bellia S, Musozoda M, Tolbert JN, Zeller M, Mirjafari A, Hillesheim PC.   +8 more
europepmc   +1 more source

A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm. [PDF]

Bone Marrow Transplant
Rampotas A, Aspa-Cilleruelo JM, Koster L, Avenoso D, Passweg J, Sala E, Robin M, Myhre AE, de Witte M, Nur E, Chevallier P, Schroeder T, Srour M, Chiusolo P, Salmenniemi U, Verbeek M, Finazzi MC, Castilla-Llorente C, Rubio MT, Sobieralski P, Sockel K, Alabdulkarim A, Drozd-Sokolowska J, Raj K, Battipaglia G, Czerw T, Polverelli N, Hernández-Boluda JC, McLornan DP.   +28 more
europepmc   +1 more source

Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high-risk MECOM-rearranged AML. [PDF]

Hemasphere
Fiskus W, Mill CP, Piel J, Collins M, Hentemann M, Cuglievan B, Birdwell CE, Das K, Davis JA, Hou H, Jain A, Malovannaya A, Flores LB, Kadia TM, Daver N, Sasaki K, Takahashi K, Hammond D, Wang J, Loghavi S, Su X, DiNardo CD, Delwel R, Bhalla KN.   +23 more
europepmc   +1 more source

Acute resistance to BET inhibitors remodels compensatory transcriptional programs via p300 coactivation. [PDF]

Blood
Shah V, Giotopoulos G, Osaki H, Meyerhöfer M, Meduri E, Gallego-Crespo A, Behrendt MA, Saura-Pañella M, Tarkar A, Schubert B, Yun H, Horton SJ, Agrawal-Singh S, Haehnel PS, Basheer F, Lugo D, Eleftheriadou I, Barbash O, Dhar A, Kühn MWM, Guezguez B, Theobald M, Kindler T, Gallipoli P, Yeh P, Dawson MA, Prinjha RK, Huntly BJP, Sasca D.   +28 more
europepmc   +1 more source

Gene therapy in transfusion-dependent non-β0/β0 genotype β-thalassemia: first real-world experience of beti-cel. [PDF]

Blood Adv
Mirza A, Ritsert ML, Tao G, Thakar H, Lobitz S, Heine S, Koscher L, Dürken M, Schmitt A, Schmitt M, Pavel P, Laier S, Jakoby D, Greil J, Kunz J, Kulozik A.   +15 more
europepmc   +1 more source